US 10738030
Modulators of cystic fibrosis transmembrane conductance regulator
granted A61PA61P11/00
Quick answer
US patent 10738030 (Modulators of cystic fibrosis transmembrane conductance regulator) held by Vertex Pharmaceuticals Incorporated expires Mon Aug 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Aug 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 48
- CPC classes
- A61P, A61P11/00